| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
557 |
| issn |
2218-6751
2226-4477 |
| issueIdentifier |
4 |
| pageRange |
556-557 |
| publicationName |
Translational Lung Cancer Research |
| startingPage |
556 |
| bibliographicCitation |
Editorial Office. The first attempt worldwide to test PD-1 antibody on multiple "Stage 0" lung cancer. Transl Lung Cancer Res. 2019 Aug;8(4):556–7. PMID: 31555532; PMCID: PMC6749131. |
| date |
201908 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/31555532
https://pubmed.ncbi.nlm.nih.gov/PMC6749131
https://doi.org/10.21037/tlcr.2019.08.01 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/43494
https://portal.issn.org/resource/ISSN/2218-6751
https://portal.issn.org/resource/ISSN/2226-4477 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
The first attempt worldwide to test PD-1 antibody on multiple “Stage 0” lung cancer |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b83d04d3e3b05ce10d1a5893dc850a9b
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8366 |